Drotaverine Hcl Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 20mg, 40mg, 80mg
Reference Brands: No-Spa (EU)
Category:
Analgesic
It belongs to the phosphodiesterase 4 group of inhibitors not having any anticholinergic properties.
Drotaverine HCL Injection is available in Injection
and strengths such as 20mg, 40mg, 80mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Drotaverine HCL Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Drotaverine HCL Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
This is used to provide relief against the pain caused due to menstruation, gallbladder stones, kidney stones, muscles spasms, headaches, and irritable bowel syndrome.
It is commonly used to manage spasms of the gastrointestinal tract, urinary system, and biliary tract, helping to relieve conditions such as abdominal pain, renal colic, and gall bladder discomfort. Drotaverine is also used in gynecological practice to ease menstrual cramps and is known to support cervical dilation during labor, thereby facilitating childbirth.
Due to its targeted action on smooth muscles, drotaverine provides effective and rapid relief from spasm-related pain while maintaining a good safety profile. It is available in oral and injectable forms and is widely used in clinical settings for the management of acute and chronic spasmodic conditions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing